
Emily Razaqi serves as senior vice president, Global Supply Chain at Amgen, where she leads the company’s global supply chain as a critical enterprise capability. She is responsible for connecting Amgen’s manufacturing network with the needs of its global business, partnering across functions to enable the company’s growth ambitions and help ensure reliable supply of medicines for patients around the world.
Razaqi brings broad experience across operations, commercial strategy and enterprise leadership to the role. Since joining Amgen in 2004, she has held leadership positions across the company and around the world, including senior vice president, Obesity and Related Conditions; general manager of Amgen’s Biosimilars business; senior vice president, Corporate Affairs; and vice president and site head of Amgen Singapore Manufacturing.
Emily plays a central role in bringing together supply chain, manufacturing and commercial capabilities to support Amgen’s growth and reach millions more patients globally. Her experience spans global product strategy, portfolio execution, manufacturing, operations and corporate affairs, giving her a broad perspective across the lifecycle of Amgen’s medicines.
Emily serves as Chair of the Amgen Foundation and executive sponsor of the Amgen Asian Association employee resource group. She earned her bachelor’s degree in Industrial Engineering and master’s degree in Industrial Engineering and Engineering Management from Stanford University.